USE OF 3-O-SULFAMOYLOXY-7β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE TO TREAT BREAST CANCER

摘要

The invention relates to the field of medicine and to the chemical and pharmaceutical industry, and concerns agents for treating breast cancer. Described is the use of 3-O-sulfamoyloxy-7β-methyl-D-homo-6-oxaestra-1,3,5(10),8(9)-tetraen-17a-one as an anti-cancer agent in monotherapy and adjuvant therapy for breast cancer, including triple-negative breast cancer.